GenBio AI unveils AIDO Cell, a virtual model to simulate whole human cells
GenBio AI introduced AIDO Cell, a digital platform that simulates an entire human cell and predicts how it reacts to genetic or drug interventions.
GenBio AI, headquartered in Palo Alto, announced the release of AIDO Cell, a comprehensive virtual cell platform that renders proteins, RNA and DNA within a simulated cellular landscape. Researchers can virtually disable genes or add compounds and observe predicted alterations across the entire molecular system. The effort expands on DeepMind's AlphaFold, which predicts individual protein structures, by aiming to model the dynamics of a whole cell's machinery.
David Baker, a University of Washington scientist and co-founder who shared the 2024 Nobel Prize in chemistry for computational protein design, likened the technology to viewing an entire city rather than a single house. By enabling rapid in-silico experiments, AIDO Cell could speed up drug discovery and fundamental biology studies. The launch marks a significant advance in applying artificial intelligence to systems-level biology.
Why it matters
A virtual cell model could dramatically speed up drug development and biological research by allowing rapid, computer-based experiments.
In this story
